HCD, part of Prime, is a health economics and outcomes research team specializing in evidence that informs and challenges healthcare decisions.
Prime HCD is a part of Prime's expanding Evidence & Access capability, working alongside Prime Access and US-based Prime Aventine to deliver integrated support across global markets.
Our multidisciplinary team spans market access, HEOR, real-world evidence, and value strategy.
With unified leadership across these groups, we provide an integrated value proposition—helping clients navigate increasingly complex global environments and prepare their products for sustainable and successful market entry.
In summary we provide:
- Full HEOR and RWE capabilities
- Deep US‑focused market access and payer engagement expertise
- Value dossiers, payer evidence packages, and pre-approval materials
- Reimbursement and access strategy backed by real‑world and economic evidence
- Integrated value communication across scientific, medical, and HEOR domains